Helena Strigård and Nick Roelofs join PeptiSystems’ Board of Directors to support global expansion

18th of June, 2025 - Uppsala, Sweden,

​​​

PeptiSystems, a biotech company specializing in innovative manufacturing solutions for peptide and oligonucleotide drugs, has appointed Helena Strigård and Nick Roelofs to its Board of Directors – two prominent leaders in Swedish and international life science. Their appointments come at a pivotal moment as the company scales commercialization and global presence, with a particular focus on large-scale peptide production.

​

Increasing demand for PeptiSystems’ technology over the past year has driven new customer collaborations, partnerships, and a growing need for strategic support in the company’s expansion. A strengthened board will play a key role in the company’s continued international development.

​

Helena Strigård brings leadership experience from both the life science industry and the public sector. She previously served as Director General of SwedenBIO, the Swedish life science industry organization, where she played a key role in building connections between Nordic and international clusters. She has also been CEO of NorthX Biologics, served as an advisor at the Swedish Ministry of Finance, and held roles at Vinnova, BusinessEurope in Brussels, and the Confederation of Swedish Enterprise. Today, she is CEO of Ventures Accelerated, a network of investors and advisors supporting growth-stage life science companies worldwide.

​

“PeptiSystems combines strong innovation with the potential to become a leading player in next-generation peptide manufacturing. I look forward to contributing with strategic direction and international networks as the company enters its next phase of growth,” says Helena Strigård.

​

Nick Roelofs brings over 40 years of international leadership experience in life science and has a track record of driving growth in global companies focused on advanced analytical instruments, diagnostics, and commercialisation of research-intensive technologies. As President of the Life Sciences Group at Agilent Technologies, he led a USD 3 billion business unit. He has also held key leadership roles at Bio-Rad Laboratories and served as an advisor to Summa Equity and Nordic Capital, where he contributed to investments in Olink, including its acquisition by Thermo Fisher for SEK 34 billion.

​

“PeptiSystems’ technology brings new efficiency and scalability to peptide synthesis – capabilities that are increasingly critical as global demand grows. I’m delighted to support the company’s ambition to take a leading position in large-scale peptide manufacturing, drawing on my experience in global expansion and industrial partnerships,” says Nick Roelofs.

​

“We’re thrilled to welcome Helena Strigård and Nick Roelofs to the board. Helena has a unique ability to navigate the intersections of industry, policy, and finance – and has played a key role in developing Sweden’s life science ecosystem. Nick brings scientific insights, business leadership, and strategic depth, with deep experience in global growth and partnerships. Their combined strengths will further reinforce our position as we scale our technology for large-scale peptide production,” says Karin Granath, CEO of PeptiSystems.

 

For more information, please contact:
Karin Granath, CEO
Phone: +46 702-82 07 47
Email: karin.granath@peptisystems.com  

 

About PeptiSystems AB
PeptiSystems is a biotech company developing a new generation of flow-through instruments for peptide and oligonucleotide therapeutics synthesis. Utilizing proprietary flow-through column technology, PeptiSystems' instruments significantly reduce production times, enhance synthesis control, and minimize raw material consumption while maintaining high purity and yield. With scalability in mind, these next-generation synthesis instruments seamlessly adapt from small-scale development to large-scale production, enabling pharmaceutical companies and CDMOs to meet the growing global demand for high-performance, cost-effective, and sustainable manufacturing processes. PeptiSystems is headquartered in Uppsala, Sweden. For more information, please visit www.peptisystems.com and follow us on LinkedIn.